These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 18834326)

  • 1. CHEK2 I157T and endometrial cancer.
    Konstantinova DV; Kadiyska TK; Kaneva RP; Tosheva EG; Guseva VT; Dimitrov BH; Dimitrov RG; Doganov NI; Ivanov SI; Kremensky IM; Mitev VI
    DNA Cell Biol; 2009 Jan; 28(1):9-12. PubMed ID: 18834326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHEK2 I157T and colorectal cancer in Bulgaria.
    Konstantinova D; Kadiyska T; Sokolova V; Kaneva R; Mirchev M; Savov A; Aleksandrova A; Nedin D; Kostadinov E; Damyanov D; Kremensky I; Mitev V
    J BUON; 2010; 15(2):314-7. PubMed ID: 20658728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk.
    Einarsdóttir K; Humphreys K; Bonnard C; Li Y; Li Y; Chia KS; Liu ET; Hall P; Liu J; Wedrén S
    Hum Mol Genet; 2007 Jan; 16(2):154-64. PubMed ID: 17164260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHEK2 I157T associates with familial and sporadic colorectal cancer.
    Kilpivaara O; Alhopuro P; Vahteristo P; Aaltonen LA; Nevanlinna H
    J Med Genet; 2006 Jul; 43(7):e34. PubMed ID: 16816021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHEK2 variant I157T may be associated with increased breast cancer risk.
    Kilpivaara O; Vahteristo P; Falck J; Syrjäkoski K; Eerola H; Easton D; Bartkova J; Lukas J; Heikkilä P; Aittomäki K; Holli K; Blomqvist C; Kallioniemi OP; Bartek J; Nevanlinna H
    Int J Cancer; 2004 Sep; 111(4):543-7. PubMed ID: 15239132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysis.
    Han FF; Guo CL; Liu LH
    DNA Cell Biol; 2013 Jun; 32(6):329-35. PubMed ID: 23713947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHEK2 1100delC, IVS2+1G>A and I157T mutations are not present in colorectal cancer cases from Turkish population.
    Bayram S; Topaktaş M; Akkız H; Bekar A; Akgöllü E
    Cancer Epidemiol; 2012 Oct; 36(5):453-7. PubMed ID: 22521562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populations.
    Kaufman B; Laitman Y; Gronwald J; Winqvist R; Irmejs A; Lubinski J; Pylkäs K; Gardovskis J; Miklasevics E; Friedman E
    Fam Cancer; 2009; 8(4):473-8. PubMed ID: 19609724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk.
    O'Mara TA; Ferguson K; Fahey P; Marquart L; Yang HP; Lissowska J; Chanock S; Garcia-Closas M; Thompson DJ; Healey CS; Dunning AM; Easton DF; ; Webb PM; Spurdle AB
    Twin Res Hum Genet; 2011 Aug; 14(4):328-32. PubMed ID: 21787115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations.
    Cybulski C; Górski B; Huzarski T; Byrski T; Gronwald J; Debniak T; Wokolorczyk D; Jakubowska A; Serrano-Fernández P; Dork T; Narod SA; Lubinski J
    J Med Genet; 2009 Feb; 46(2):132-5. PubMed ID: 18930998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer.
    Domagala P; Wokolorczyk D; Cybulski C; Huzarski T; Lubinski J; Domagala W
    Breast Cancer Res Treat; 2012 Apr; 132(3):937-45. PubMed ID: 21701879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?
    Cybulski C; Wokołorczyk D; Kładny J; Kurzawski G; Suchy J; Grabowska E; Gronwald J; Huzarski T; Byrski T; Górski B; D Ecedil Bniak T; Narod SA; Lubiński J
    Eur J Hum Genet; 2007 Feb; 15(2):237-41. PubMed ID: 17106448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CHEK2 I157T variant and breast cancer susceptibility: a systematic review and meta-analysis.
    Liu C; Wang Y; Wang QS; Wang YJ
    Asian Pac J Cancer Prev; 2012; 13(4):1355-60. PubMed ID: 22799331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study.
    Brennan P; McKay J; Moore L; Zaridze D; Mukeria A; Szeszenia-Dabrowska N; Lissowska J; Rudnai P; Fabianova E; Mates D; Bencko V; Foretova L; Janout V; Chow WH; Rothman N; Chabrier A; Gaborieau V; Odefrey F; Southey M; Hashibe M; Hall J; Boffetta P; Peto J; Peto R; Hung RJ
    Hum Mol Genet; 2007 Aug; 16(15):1794-801. PubMed ID: 17517688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHEK2 gene alterations in the forkhead-associated domain, 1100delC and del5395 do not modify the risk of sporadic pancreatic cancer.
    Mohelnikova-Duchonova B; Havranek O; Hlavata I; Foretova L; Kleibl Z; Pohlreich P; Soucek P
    Cancer Epidemiol; 2010 Oct; 34(5):656-8. PubMed ID: 20643596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of CHEK2 forkhead-associated domain increase the risk of Hodgkin lymphoma.
    Havranek O; Spacek M; Hubacek P; Mocikova H; Markova J; Trneny M; Kleibl Z
    Neoplasma; 2011; 58(5):392-5. PubMed ID: 21744992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphism of pi-class glutathione s-transferase and susceptibility to endometrial carcinoma.
    Chan QK; Khoo US; Ngan HY; Yang CQ; Xue WC; Chan KY; Chiu PM; Ip PP; Cheung AN
    Clin Cancer Res; 2005 Apr; 11(8):2981-5. PubMed ID: 15837751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors.
    Szymanska-Pasternak J; Szymanska A; Medrek K; Imyanitov EN; Cybulski C; Gorski B; Magnowski P; Dziuba I; Gugala K; Debniak B; Gozdz S; Sokolenko AP; Krylova NY; Lobeiko OS; Narod SA; Lubinski J
    Gynecol Oncol; 2006 Sep; 102(3):429-31. PubMed ID: 16828850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer.
    Zhang S; Lu J; Zhao X; Wu W; Wang H; Lu J; Wu Q; Chen X; Fan W; Chen H; Wang F; Hu Z; Jin L; Wei Q; Shen H; Huang W; Lu D
    Carcinogenesis; 2010 Jul; 31(7):1251-8. PubMed ID: 20462940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population.
    Kleibl Z; Havranek O; Hlavata I; Novotny J; Sevcik J; Pohlreich P; Soucek P
    Eur J Cancer; 2009 Mar; 45(4):618-24. PubMed ID: 18996005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.